The general aim of this project is to understand how the activities of the Jun and Fos families of transcriptions factors implicated in the proliferative response of mammalian cells to growth factors are regulated by interaction with other proteins.
The specific aims are 1) to characterize the interactions of recently discovered proteins with Jun or Fos family members, 2) to determine the functional effects of the interactions, and 3) to identify other proteins that regulate Jun and Fos. The recently discovered proteins that interact with Jun or Fos were identified in the yeast two hybrid system. One is a DNA-binding homeodomain protein, another a novel leucine zipper protein, and a third is the mammalian homolog of the yeast transcriptional regulator SUG1. An early objective is to determine by mutagenesis the structural requirements for the interaction of each protein with the relevant domain of Jun or Fos. In the case of the first two proteins, effects on the transcriptional activities of Jun or Fos in transfected cells have been demonstrated, and effects of the third will be tested. The structural requirements for the transcriptional effects will then be correlated with the requirements for interaction with Jun or Fos. In the case of mammalian Sug1, anti-Sug1 antibodies will be used to determine if Sug1 is present in cell nuclei as a multiprotein complex, as recently reported for S. cerevisiae. If so, the complex will be purified and its interaction with c-Fos and related transcription factors will be explored. Finally, in collaboration with Jeff Boeke's laboratory, other proteins that regulate the activities of Jun and Fos will be identified using a sensitive two hybrid yeast system developed in Dr. Boeke's laboratory.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA016519-24
Application #
6268918
Study Section
Project Start
1998-05-01
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
24
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Janes, K; Symons-Liguori, A M; Jacobson, K A et al. (2016) Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol 173:1253-67
Oh, Sekyung; Kato, Masaki; Zhang, Chi et al. (2015) A Comparison of Ci/Gli Activity as Regulated by Sufu in Drosophila and Mammalian Hedgehog Response. PLoS One 10:e0135804
Price, Jessica C; Pollock, Lana M; Rudd, Meghan L et al. (2014) Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One 8:e63313
O'Donnell, Kathryn A; An, Wenfeng; Schrum, Christina T et al. (2013) Controlled insertional mutagenesis using a LINE-1 (ORFeus) gene-trap mouse model. Proc Natl Acad Sci U S A 110:E2706-13
Newman, Robert H; Hu, Jianfei; Rho, Hee-Sool et al. (2013) Construction of human activity-based phosphorylation networks. Mol Syst Biol 9:655
Gnanakkan, Veena P; Jaffe, Andrew E; Dai, Lixin et al. (2013) TE-array--a high throughput tool to study transposon transcription. BMC Genomics 14:869
Rybanska-Spaeder, Ivana; Reynolds, Taylor L; Chou, Jeremy et al. (2013) 53BP1 is limiting for NHEJ repair in ATM-deficient model systems that are subjected to oncogenic stress or radiation. Mol Cancer Res 11:1223-34
Le Gallo, Matthieu; O'Hara, Andrea J; Rudd, Meghan L et al. (2012) Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet 44:1310-5
O'Donnell, Kathryn A; Keng, Vincent W; York, Brian et al. (2012) A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 109:E1377-86
Burns, Kathleen H; Boeke, Jef D (2012) Human transposon tectonics. Cell 149:740-52

Showing the most recent 10 out of 246 publications